ONEMEDNET CORP (ONMD)

US68270C1036 - Common Stock

0.6874  -0.01 (-1.09%)

After market: 0.653 -0.03 (-5%)

Fundamental Rating

1

Taking everything into account, ONMD scores 1 out of 10 in our fundamental rating. ONMD was compared to 39 industry peers in the Health Care Technology industry. ONMD may be in some trouble as it scores bad on both profitability and health. ONMD is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

ONMD had negative earnings in the past year.
ONMD had a positive operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -5888.61%, ONMD is doing worse than 97.30% of the companies in the same industry.
Industry RankSector Rank
ROA -5888.61%
ROE N/A
ROIC N/A
ROA(3y)-1675.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ONMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

ONMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ONMD has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ONMD is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -274.12, we must say that ONMD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -274.12, ONMD is doing worse than 97.30% of the companies in the same industry.
ONMD has a debt to FCF ratio of 0.26. This is a very positive value and a sign of high solvency as it would only need 0.26 years to pay back of all of its debts.
ONMD has a Debt to FCF ratio of 0.26. This is amongst the best in the industry. ONMD outperforms 89.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.26
Altman-Z -274.12
ROIC/WACCN/A
WACC7.46%

2.3 Liquidity

A Current Ratio of 0.03 indicates that ONMD may have some problems paying its short term obligations.
ONMD has a Current ratio of 0.03. This is amonst the worse of the industry: ONMD underperforms 97.30% of its industry peers.
A Quick Ratio of 0.03 indicates that ONMD may have some problems paying its short term obligations.
ONMD has a worse Quick ratio (0.03) than 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03

0

3. Growth

3.1 Past

ONMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10079.65%.
The Revenue for ONMD has decreased by -11.37% in the past year. This is quite bad
EPS 1Y (TTM)-10079.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-329.97%
Revenue 1Y (TTM)-11.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ONMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ONMD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.83
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ONMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ONEMEDNET CORP

NASDAQ:ONMD (10/17/2024, 8:55:10 PM)

After market: 0.653 -0.03 (-5%)

0.6874

-0.01 (-1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap23.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5888.61%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-10079.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.37%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y